Browsing by Author "7dae5b51-3bf2-46a2-bac1-5878d8e085f9"

Now showing items 1-4 of 4

    • Incidence of virological failure and major regimen change of initial combination antiretroviral therapy in ... 
      Array, Array; Cesar, Carina; Jenkins, Cathy A.; Shepherd, Bryan E.; Padgett, Denis; Mejía, Fernando; Ribeiro, Sayonara Rocha; Cortés Moncada, Claudia; Pape, Jean W.; Madero, Juan Sierra; Fink, Valeria; Sued, Omar; McGowan, Catherine; Cahn, Pedro; Grinsztejn, Beatriz; Reyes, (Elsevier Ltd, 2015)
      © 2015 Elsevier Ltd. Background: Access to combination antiretroviral therapy (ART) is expanding in Latin America (Mexico, Central America, and South America) and the Caribbean. We assessed the incidence of and factors ...
    • Rates and reasons for early change of first HAART in HIV-1-infected patients in 7 sites throughout the ... 
      Cesar, Carina; Shepherd, Bryan E.; Krolewiecki, Alejandro J.; Fink, Valeria I.; Schechter, Mauro; Tuboi, Suely H.; Wolff Reyes, Marcelo; Pape, Jean W.; Leger, Paul; Padgett, Denis; Madero, Juan Sierra; Gotuzzo, Eduardo; Sued, Omar; Mcgowan, Catherine C.; Masys, Daniel R.; Cah (2010)
      Background: HAART rollout in Latin America and the Caribbean has increased from approximately 210,000 in 2003 to 390,000 patients in 2007, covering 62% (51%-70%) of eligible patients, with considerable variation among ...
    • The HIV epidemic in Latin America: a time to reflect on the history of success and the challenges ahead 
      Crabtree Ramírez, Brenda; Belaunzarán Zamudio, Pablo; Cortes, Claudia; Morales, Miguel; Sued, Omar; Sierra Madero, Juan; Cahn, Pedro; Pozniak, Anton; Grinsztejn, Beatriz (John Wiley & Sons, 2020)
    • Use of third line antiretroviral therapy in Latin America 
      Cesar, Carina; Shepherd, Bryan E.; Jenkins, Cathy A.; Ghidinelli, Massimo; Castro, Jose Luis; Veloso, Valdiléa Gonçalves; Cortés, Claudia P.; Padgett, Denis; Crabtree Ramírez, Brenda; Gotuzzo, Eduardo; Fink, Valeria; Duran, Adriana; Sued, Omar; McGowan, Catherine C. (Public Library of Science, 2014)
      © PLOS ONE 2014. Background: Access to highly active antiretroviral therapy (HAART) is expanding in Latin America. Many patients require second and third line therapy due to toxicity, tolerability, failure, or a combination ...